These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27559710)

  • 21. Tackling HIV and AIDS: contributions by non-human primate models.
    Van Rompay KKA
    Lab Anim (NY); 2017 May; 46(6):259-270. PubMed ID: 28530684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerating HIV vaccine development using non-human primate models.
    Rahman MA; Robert-Guroff M
    Expert Rev Vaccines; 2019 Jan; 18(1):61-73. PubMed ID: 30526159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing vaccine effects in repeated low-dose challenge experiments.
    Hudgens MG; Gilbert PB
    Biometrics; 2009 Dec; 65(4):1223-32. PubMed ID: 19397589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surrogates of protection in repeated low-dose challenge experiments.
    Long DM; Hudgens MG; Wu CD
    Stat Med; 2015 May; 34(10):1747-60. PubMed ID: 25628249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection.
    Lopker MJ; Del Prete GQ; Estes JD; Li H; Reid C; Newman L; Lipkey L; Camus C; Easlick JL; Wang S; Decker JM; Bar KJ; Learn G; Pal R; Weiss DE; Hahn BH; Lifson JD; Shaw GM; Keele BF
    J Virol; 2016 Oct; 90(19):8435-53. PubMed ID: 27412591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards an AIDS vaccine: the role of nonhuman primates.
    Nathanson N; Mathieson BJ
    J Med Primatol; 1999; 28(4-5):146-53. PubMed ID: 10593479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1999; 28(4-5):249-73. PubMed ID: 10593492
    [No Abstract]   [Full Text] [Related]  

  • 28. Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy.
    Palermo RE; Patterson LJ; Aicher LD; Korth MJ; Robert-Guroff M; Katze MG
    J Virol; 2011 Jan; 85(2):1099-116. PubMed ID: 21068249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is an HIV vaccine possible?
    Wilson NA; Watkins DI
    Braz J Infect Dis; 2009 Aug; 13(4):304-10. PubMed ID: 20231996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-human primate models for AIDS vaccine research.
    Hu SL
    Curr Drug Targets Infect Disord; 2005 Jun; 5(2):193-201. PubMed ID: 15975024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.
    Franchini G; Gurunathan S; Baglyos L; Plotkin S; Tartaglia J
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S75-88. PubMed ID: 15285707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.
    Clarke DK; Nasar F; Chong S; Johnson JE; Coleman JW; Lee M; Witko SE; Kotash CS; Abdullah R; Megati S; Luckay A; Nowak B; Lackner A; Price RE; Little P; Kalyan N; Randolf V; Javadian A; Zamb TJ; Parks CL; Egan MA; Eldridge J; Hendry M; Udem SA
    J Virol; 2014 Jun; 88(12):6690-701. PubMed ID: 24696472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.
    Staprans SI; Feinberg MB; Shiver JW; Casimiro DR
    Curr Opin HIV AIDS; 2010 Sep; 5(5):377-85. PubMed ID: 20978377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine.
    Nishimura Y; Martin MA
    Curr Opin Virol; 2011 Sep; 1(3):204-10. PubMed ID: 21909345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.
    Stott EJ; Almond N; Kent K; Walker B; Hull R; Rose J; Silvera P; Sangster R; Corcoran T; Lines J; Silvera K; Luciw P; Murphy-Corb M; Momin P; Bruck C
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():423-32. PubMed ID: 9519819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.
    Flatz L; Cheng C; Wang L; Foulds KE; Ko SY; Kong WP; Roychoudhuri R; Shi W; Bao S; Todd JP; Asmal M; Shen L; Donaldson M; Schmidt SD; Gall JG; Pinschewer DD; Letvin NL; Rao S; Mascola JR; Roederer M; Nabel GJ
    J Virol; 2012 Aug; 86(15):7760-70. PubMed ID: 22593152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates.
    Xiao P; Dienger-Stambaugh K; Chen X; Wei H; Phan S; Beavis AC; Singh K; Adhikary NRD; Tiwari P; Villinger F; He B; Spearman P
    Front Immunol; 2021; 12():623996. PubMed ID: 33717130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates.
    Keating SM; Heitman JW; Wu S; Deng X; Stacey AR; Zahn RC; de la Rosa M; Finstad SL; Lifson JD; Piatak M; Gauduin MC; Kessler BM; Ternette N; Carville A; Johnson RP; Desrosiers RC; Letvin NL; Borrow P; Norris PJ; Schmitz JE
    J Virol; 2016 Nov; 90(22):10339-10350. PubMed ID: 27630228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nonhuman primate models to develop mucosal AIDS vaccines.
    Genescà M; Miller CJ
    Curr HIV/AIDS Rep; 2010 Feb; 7(1):19-27. PubMed ID: 20425054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.